Showing results (191-200 of 240) with videos related to

Sort By:
Pageof 24
Haematologica|May 30, 2008
Prognostic impact of genetic characterization in the GIMEMA LAM99P multicenter study for newly diagnosed acute myeloid leukemiaFrancesco Lo-Coco, Antonio Cuneo, Fabrizio Pane, et al.
Haematologica|August 10, 2012
Association between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia patients receiving imatinib therapySabrina Angelini, Simona Soverini, Gloria Ravegnini, et al.
Bone Marrow Transplantation|July 27, 2021
Lymphoid and myeloid immune cell reconstitution after nicotinamide-expanded cord blood transplantationCoco de Koning, Weiyang Tao, Amelia Lacna, et al.
Blood|July 25, 2008
Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistanceIlaria Iacobucci, Annalisa Lonetti, Francesca Messa, et al.
Blood|July 25, 2009
Endothelial colony-forming cells from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality markerGiovanna Piaggio, Vittorio Rosti, Mirko Corselli, et al.
American Journal of Hematology|April 3, 2016
Epidemiology and clinical relevance of mutations in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 359 patients of the AGIMM groupGiada Rotunno, Annalisa Pacilli, Valentina Artusi, et al.
Haematologica|October 8, 2008
Identification of different Ikaros cDNA transcripts in Philadelphia-positive adult acute lymphoblastic leukemia by a high-throughput capillary electrophoresis sizing methodIlaria Iacobucci, Annalisa Lonetti, Daniela Cilloni, et al.
European Journal of Haematology|March 4, 2014
Deferasirox for transfusion-dependent patients with myelodysplastic syndromes: safety, efficacy, and beyond (GIMEMA MDS0306 Trial)Emanuele Angelucci, Valeria Santini, Anna Angela Di Tucci, et al.
Blood|February 15, 2007
Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemiaJelena V Jovanovic, Joannah Score, Katherine Waghorn, et al.
American Journal of Blood Research|July 5, 2012
Quality of life and physicians' perception in myelodysplastic syndromesEsther Natalie Oliva, Carlo Finelli, Valeria Santini, et al.
Pageof 24